| Bevacizumab plus irinotecan in recurrent glioblastoma multiforme JJ Vredenburgh, A Desjardins, JE Herndon, J Marcello, DA Reardon, ... Journal of clinical oncology 25 (30), 4722-4729, 2007 | 1698 | 2007 |
| Stem cell–like glioma cells promote tumor angiogenesis through vascular endothelial growth factor S Bao, Q Wu, S Sathornsumetee, Y Hao, Z Li, AB Hjelmeland, Q Shi, ... Cancer research 66 (16), 7843-7848, 2006 | 1627 | 2006 |
| Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Z Li, S Bao, Q Wu, H Wang, C Eyler, S Sathornsumetee, Q Shi, Y Cao, ... Cancer cell 15 (6), 501-513, 2009 | 1498 | 2009 |
| Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma JJ Vredenburgh, A Desjardins, JE Herndon, JM Dowell, DA Reardon, ... Clinical cancer research 13 (4), 1253-1259, 2007 | 1274 | 2007 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The Lancet Oncology 18 (10), 1373-1385, 2017 | 947 | 2017 |
| Targeting cancer stem cells through L1CAM suppresses glioma growth S Bao, Q Wu, Z Li, S Sathornsumetee, H Wang, RE McLendon, ... Cancer research 68 (15), 6043-6048, 2008 | 539 | 2008 |
| Molecularly targeted therapy for malignant glioma S Sathornsumetee, DA Reardon, A Desjardins, JA Quinn, JJ Vredenburgh, ... Cancer 110 (1), 13-24, 2007 | 439 | 2007 |
| Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme DA Reardon, MJ Egorin, JA Quinn, JN Rich Sr, I Gururangan, ... Journal of Clinical Oncology 23 (36), 9359-9368, 2005 | 373 | 2005 |
| Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan S Sathornsumetee, Y Cao, JE Marcello, JE Herndon, RE McLendon, ... Journal of clinical oncology: official journal of the American Society of …, 2008 | 310 | 2008 |
| Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma S Sathornsumetee, A Desjardins, JJ Vredenburgh, RE McLendon, ... Neuro-oncology 12 (12), 1300-1310, 2010 | 253 | 2010 |
| SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility MD Hjelmeland, AB Hjelmeland, S Sathornsumetee, ED Reese, ... Molecular cancer therapeutics 3 (6), 737-745, 2004 | 248 | 2004 |
| Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study DA Reardon, A Desjardins, JJ Vredenburgh, S Gururangan, JH Sampson, ... British journal of cancer 101 (12), 1986-1994, 2009 | 226 | 2009 |
| Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma DA Reardon, JA Quinn, JJ Vredenburgh, S Gururangan, AH Friedman, ... Clinical Cancer Research 12 (3), 860-868, 2006 | 216 | 2006 |
| Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas A Desjardins, DA Reardon, JE Herndon, J Marcello, JA Quinn, JN Rich, ... Clinical Cancer Research 14 (21), 7068-7073, 2008 | 201 | 2008 |
| Diagnosis and treatment of high-grade astrocytoma S Sathornsumetee, JN Rich, DA Reardon Neurologic clinics 25 (4), 1111-1139, 2007 | 180 | 2007 |
| New treatment strategies for malignant gliomas S Sathornsumetee, JN Rich Expert review of anticancer therapy 6 (7), 1087-1104, 2006 | 160 | 2006 |
| Designer therapies for glioblastoma multiforme S Sathornsumetee, JN Rich Annals of the New York Academy of Sciences 1142 (1), 108-132, 2008 | 149 | 2008 |
| Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas A Desjardins, JA Quinn, JJ Vredenburgh, S Sathornsumetee, ... Journal of neuro-oncology 83, 53-60, 2007 | 133 | 2007 |
| ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system … JN Rich, S Sathornsumetee, ST Keir, MW Kieran, A Laforme, A Kaipainen, ... Clinical Cancer Research 11 (22), 8145-8157, 2005 | 121 | 2005 |
| Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma DA Reardon, JA Quinn, JN Rich, A Desjardins, J Vredenburgh, ... Cancer 104 (7), 1478-1486, 2005 | 96 | 2005 |
